article Open AccessTop 1% cited
Omalizumab, anti-IgE recombinant humanized monoclonal antibody, for the treatment of severe allergic asthma
Journal of Allergy and Clinical Immunology · 2001 · Vol. 108(2) · pp. 184–190
William W. Busse✉(UW Health University Hospital)Jonathan CorrenBobby Q. LanierMargaret McAlaryAngel FowlerTaylorGiovanni Della CioppaAndre van AsNiroo Gupta
Asthma and respiratory diseasesAllergic Rhinitis and SensitizationFood Allergy and Anaphylaxis ResearchOmalizumabMedicineAsthmaPlaceboImmunoglobulin EExacerbationDiscontinuationCorticosteroidAdverse effectInternal medicine
MeSH terms
OmalizumabAdolescentAdultAgedAntibodies, Anti-IdiotypicAntibodies, MonoclonalAsthmaChildFemaleHumansImmunoglobulin EMaleMiddle AgedRespiratory Function TestsAnti-Allergic Agents
Citations
1,287
FWCI
19.18
field-weighted impact
References
15
Percentile
100%
vs. same field & year
Citations per year
Cited by
Dual blockade of IL‐4 and IL‐13 with dupilumab, an IL‐4Rα antibody, is required to broadly inhibit type 2 inflammation
Allergy · 2019 · 458 citations
The effect of treatment with omalizumab, an anti‐IgE antibody, on asthma exacerbations and emergency medical visits in patients with severe persistent asthma
Allergy · 2004 · 399 citations
Benefits of omalizumab as add‐on therapy in patients with severe persistent asthma who are inadequately controlled despite best available therapy (GINA 2002 step 4 treatment): INNOVATE
Allergy · 2004 · 1,110 citations
Protein therapeutics: a summary and pharmacological classification
Nature Reviews Drug Discovery · 2007 · 2,066 citations
Efficacy and tolerability of anti‐immunoglobulin E therapy with omalizumab in patients with concomitant allergic asthma and persistent allergic rhinitis: SOLAR
Allergy · 2004 · 404 citations
Global strategy for asthma management and prevention: GINA executive summary
European Respiratory Journal · 2007 · 3,217 citations
Asthma phenotypes: the evolution from clinical to molecular approaches
Nature Medicine · 2012 · 2,354 citations
Citation Network
How this paper connects to the literature. Drag to explore, click any node to open that paper.